FUTURE COMBINATION TESTS

AND SYNDROMIC PANELS

Future Applications

PCR, Immunochemistry, and Chemistry Fluxergy Card, and Fluxergy Analyzer Mk 13 Prototypes

In addition to exploring saliva/throat/nasal swab sample types for our existing COVID-19 test, we are also developing tests that can utilize Fluxergy’s first-of-its-kind multimodal technology. We are designing the following tests for the existing Fluxergy Analyzer model. Our product development pipeline includes:

COVID-19 IgG Antibody Test
Combined Test for SARS-CoV-2 RNA + COVID-19 IgG (a first in multimodal testing)
Respiratory COVID-19 / Influenza /RSV PCR panel

TESTING MULTIPLE PARAMETERS

ON A SINGLE TEST CARD

Fluxergy is addressing the current bottleneck in point of care testing: Right now, point-of-care testing requires a different analyzer for each kind of test. The Fluxergy Analyzer is being designed to run individual or combination panels for the following test types:

Molecular tests like PCR

Molecular tests like PCR

Immunochemistry tests to measure proteins

Immunochemistry tests to measure proteins

Chemistry tests for analytes like electrolytes

Chemistry tests for analytes like electrolytes

Imaging cytometry tests

Imaging cytometry tests

Measuring Multiple Types of Health Parameters at Once Can Potentially:

Address the full life cycle of disease
Reduce cost and increase efficiency, with consolidated testing consumables
Improve clinical outcomes due to increased data access
Increase access to health testing